Warner Bros. Discovery, Inc.
HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR
Last updated:
Abstract:
10-oxo-6,1-dihydrobenzo[e]pyrido[1,2-c][1,3]oxazine-9-carboxylic acid derivatives of formula (I) as hepatitis B surface antigen inhibitors or pharmaceutically acceptable salts thereof, and uses of a compound of formula (I) or pharmaceutically acceptable salts thereof and pharmaceutical compositions thereof in preparation of medicaments for treatment of viral hepatitis B. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
9 Mar 2018
Issue date:
6 Feb 2020